Form 4: American Oncology Network CFO David Afshar Awarded 150,000 Shares of Class A Common Stock

David Afshar, CFO of American Oncology Network, receives 150,000 shares of Class A Common Stock, vesting over time and performance.

Summary

• David Afshar, the Chief Financial Officer of American Oncology Network, Inc. (AONC), was granted 150,000 shares of Class A Common Stock on July 16, 2024.
• The grant is for his service as CFO and Chief Operating Officer.
• 97,500 shares will vest on a time-based schedule over four years.
• 52,500 shares will vest based on a performance-based schedule.
• Both vesting schedules will accelerate upon a change in control.
• A Limited Power of Attorney was executed on June 3, 2024, appointing Erica Mallon, Stephen Spivey, Ashley Knox, and Greg Imbrogno as attorneys-in-fact for Section 16 reporting obligations.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.

Positives

• The grant of shares to the CFO aligns his interests with the company's success.
• The vesting schedule incentivizes long-term commitment and performance.
• The acceleration of vesting upon a change in control provides additional security for the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the granted shares.

Industry Context

Stock grants are a common practice in the oncology industry to incentivize and retain key executives. The vesting schedule and change in control provisions are typical components of such grants.

Comparison to Industry Standards

• Stock grants to executives are a common practice across the pharmaceutical and healthcare industries.
• Companies like Pfizer, Merck, and Johnson & Johnson routinely use stock options and grants as part of their executive compensation packages.
• The vesting schedules and performance-based criteria are generally aligned with industry benchmarks to ensure long-term value creation.

Stakeholder Impact

• Shareholders may view the stock grant as a positive incentive for the CFO to drive long-term value.
• Employees may see the grant as a sign of the company's commitment to its leadership team.

Key Dates

Keywords

Form 4, Section 16, David Afshar, American Oncology Network, AONC, Chief Financial Officer, Class A Common Stock, Stock Grant, Vesting, Power of Attorney